Categories
Uncategorized

Psychiatrist Exposes the “Chemical Imbalance” Lie of Her Own Profession in New Book

Psychiatrist Joanna Moncrieff indicts her entire industry for falsely pushing deadly drugs as a “treatment” for depression. Her conclusion: They don’t work. And she’s got the evidence to prove it. 

This was not on their Bingo card.

The psychiatric community awoke one morning in mid-January to find the foundations of their cash-cow alliance with Big Pharma yanked out from underneath them—and by one of their own.

A new history of antidepressants, authored by a psychiatrist, doesn’t so much make the case for the falsehood of the chemical treatment of depression as it does annihilate it.

Granularly researched with evidence as airtight as it is brutal, Chemically Imbalanced: The Making and Unmaking of the Serotonin Myth by Dr. Joanna Moncrieff, a professor of psychiatry at University College London, indicts and convicts her entire industry for knowingly hawking deadly drugs on the for-profit pretense of “treating” depression.

Dr. Moncrieff resolved to unmask the fraud after leading a team of five top UK and European specialists on a review of studies to determine if there was, in fact, a relationship between the chemical serotonin and depression. Since the 1960s, psychiatrists have insisted—in articles, papers, websites and every platform they could shout from—that a “below-normal” amount of the so-called “feel-good” chemical serotonin is the cause of misery. Then, with the advent of “Selective Serotonin Reuptake Inhibitor” (SSRI) antidepressants in the 1990s, “chemical imbalance” became the Golden Calf psychiatrists and pharmaceutical giants worshipped: Simply jack up the depressed person’s serotonin with antidepressant snake-oil drugs that enrich psychiatrists and Big Pharma and thus remedy that “chemical imbalance.”

But Dr. Moncrieff and her team have thrown cold water on the “you’re-depressed-because-you-need-your-chemicals-rebalanced” party. In findings published in the journal Molecular Psychiatry, she concluded that “there is no evidence of a connection between reduced serotonin levels of activity and depression.”

Read the rest of this article here.

Categories
Uncategorized

New Research Finds Dangerous Psychedelic Drugs Misrepresented by Psychiatry

With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies are pushing back.

A profiteering pack of psychiatrists have a new money horse to ride into town: trippy hallucinogenic drugs to “cure” every ailment from depression to addiction to anxiety to schizophrenia.

Excited reports from “studies” praise the effects of the brain-scrambling drugs. Just hop on the hokum train, grab a bottle of whatever psychedelic mixture they’re peddling this week, take a big old swig and—they swear—overnight you’ll be right as rain. And, they claim, a growing body of clinical trials say it’s so. Scads of them are currently underway on various psychedelic drugs, from the date-rape drug ketamine to psilocybin and even LSD.

But a daring and concerned group of researchers at the University of Rennes in France has gone against the money-grubbing psychiatric trend, leading a new study of existing clinical trial reports. The researchers found that psychedelics have been wildly misrepresented, inaccurate claims of study results have been improperly exaggerated and the dangers of the drugs have been seriously minimized.

Read the full article here.

Categories
Uncategorized

CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

By CCHR National

The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted three MDMA therapy research papers for ethical violations.

Washington, DC – August 13, 2024 — The U.S. Food and Drug Administration (FDA) has rejected the psychedelic drug MDMA, commonly known as ecstasy or molly, as treatment for post-traumatic stress, a decision that Citizens Commission on Human Rights (CCHR) advocated in its statement submitted to the FDA during a public comment period earlier this year. The FDA’s decision ends the first attempt to gain the agency’s approval for a psychedelic drug treatment.

The FDA concurred with the findings of its advisory committee of independent experts, which held a public hearing in June on the use of MDMA for psychedelic-assisted psychotherapy. The committee voted overwhelmingly that the company which applied for drug approval, Lykos Therapeutics, failed in its clinical trials to prove the treatment was effective, and that benefits from the drug therapy did not outweigh the risks.  READ MORE

Categories
General News

CCHR Applauds California Supreme Court Decision Holding Electroshock Machine Manufacturer Liable for Brain Damage

Court concluded that company’s failure to fully disclose risks of electroshock to a physician meant that the patient also did not know the risks before undergoing the procedure, which resulted in brain damage. Citizens Commission on Human Rights warns device has never been proven safe.

By CCHR National

Washington, DC – July 10, 2024 —The California Supreme Court has issued a decision in a product liability case involving an electroshock machine which establishes that patients must receive adequate disclosure of the risks of the device prior to treatment. Citizens Commission on Human Rights (CCHR) says electroshock has never been proven safe and has known risks that include brain damage and permanent memory loss.   READ MORE

Categories
General News

Mothers’ Psychiatric Drug Use Increases Risk of Newborns Needing Urgent Medical Attention, New Research Finds

Expectant mothers considering psychiatric drugs should have the increased risks of premature birth and respiratory, circulatory, and feeding problems for their newborns fully disclosed to them by their prescribers.

by CCHR National Affairs Office

Washington, DC – June 26, 2024 — The Citizens Commission on Human Rights (CCHR), a mental health watchdog organization, is calling attention to a new study indicating the increased risks of newborns experiencing respiratory distress, circulatory distress, and feeding problems as a result of their mothers taking psychiatric drugs during pregnancy. Newborns exposed to the drugs in the womb were also more likely to have been born prematurely, researchers found. CCHR is making the research known so that expectant mothers and their prescribers can make fully informed decisions about starting or stopping the drugs.  READ MORE

Categories
General News

CCHR Observes 25th Anniversary of Columbine Mass Shooting with Call for Government Investigation into Link Between Psychiatric Drugs and Violence

Mental health watchdog also calls for laws requiring toxicology testing for psychiatric drugs for perpetrators of mass shootings and other serious violent crimes so the full extent of the risk of violence from antidepressants can be known.

by CCHR National Affairs Office

Washington, DC, April 18, 2024 — As the 25th anniversary of the Columbine school shooting approaches, the Citizens Commission on Human Rights (CCHR) is calling for a long overdue government investigation into the link between psychiatric drugs and violence.  READ MORE

Categories
General News

Citizens Commission on Human Rights Calls for Congressional Investigation into Psychiatric In-Patient Treatment, as Study Finds Suicide Risk High after Hospitalization for Depression or Attempted Suicide

Recent studies indicate patients discharged from psychiatric facilities are at greater risk for suicide than mental health patients not hospitalized, suggesting that psychiatric hospitalization itself may be a major risk factor.  Antidepressants used as treatment during hospitalization are also linked to an increased risk of suicide.

by CCHR National Affairs Office

Washington, DC, March 7, 2024 – The Citizens Commission on Human Rights (CCHR) National Affairs Office is urging Congress to investigate after a new study has found that patients released from psychiatric hospitalization for depression or attempted suicide are at the highest risk of completing suicide in the days immediately following their hospital discharge.   READ MORE

Categories
General News

Exercise is as Effective as Antidepressants or Psychotherapy in Reducing Depression, Study Finds

Researchers conclude exercise is effective in treating depression and should be offered as an evidence-based treatment option.

by CCHR National Affairs Office

The largest synthesis of data to date from research studies on the effect of exercise on depression found that exercise is as effective as antidepressant drugs or psychotherapy, the current first-line treatments for depression, and should be offered as an evidence-based treatment option. The study provides evidence for exercise as an alternative treatment for depressed individuals who do not want drugs or psychotherapy.

“This is notable as the presented results suggest exercise [qualifies] as an efficacious treatment option for depressive symptoms among individuals with depression.”

— Andreas Heissel, PhD, University of Potsdam, Germany

Researchers from seven countries set out to address the problem of the mixed results from previous meta-analyses of studies on the effect of exercise on depression. Convincing evidence was needed to enable clinicians to prescribe exercise as an evidence-based treatment option. Using updated methodology to overcome the shortcomings of previous meta-analyses, researchers analyzed the results of 41 randomized controlled trials comprising 2,264 depressed adults and compared exercise with non-exercising control groups.

Their review, published in the British Journal of Sports Medicine, showed exercise has a large effect in reducing depression symptoms. For every two depressed people treated with exercise, at least one would be expected to have a substantial reduction in depression symptoms, the researchers found.

This significant benefit was found regardless of the type or intensity of the exercise or whether done in a group or not. Aerobic exercise was more effective than resistance training, but both delivered large benefits. Moderate intensity was more beneficial than light or vigorous intensity, but all reduced depression symptoms. Supervised and group exercise were found to deliver more positive effects than unsupervised and non-group.

“The findings from this review represent the most up-to-date and comprehensive meta-analysis of the available evidence and further supports the use of exercise focusing specifically on supervised and group exercise with moderate intensity and aerobic exercise regimes,” according to the study’s lead author, Andreas Heissel, PhD, Postdoctoral Research Fellow in the Department for Sports and Health Sciences at the University of Potsdam, Germany.

The large positive effect on depression symptoms from exercise compares favorably with the results from two meta-analyses referenced in the study, one showing just a moderate effect from psychotherapy and the other showing only a small effect from antidepressants, according to Heissel.

Exercise also avoids the side effects and withdrawal symptoms associated with antidepressants and the significant expense of psychotherapy.

“This is notable as the presented results suggest exercise [qualifies] as an efficacious treatment option for depressive symptoms among individuals with depression,” wrote Heissel.

The prescribing of antidepressants was questioned in another recent study, published in Molecular Psychiatry in 2022, that found no scientific evidence to support the theory that depression is caused by a chemical imbalance of the brain, a common rationale for prescribing antidepressants. [1]

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” wrote lead researcher Joanna Moncrieff, a psychiatrist and professor at University College London. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and emotional symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuses and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Categories
General News

New Study Shows High Number Of Suicides After Electroshock

In another psychiatric treatment failure, a new study shows electroshock fails to prevent suicide, with over 800 deaths within a year in those receiving it. As with patients prescribed antidepressants, those receiving electroshock have been misled that electroshock corrects imbalanced brain chemicals.

Please read the complete article here.

Categories
General News

Study Concludes that Depression is NOT Caused by Low Serotonin Levels

According to CCHR International:

A landmark study has debunked one of the biggest mental healthcare marketing campaigns in modern history—that a “chemical imbalance in the brain causes depression” requiring antidepressants to correct it.

 

RSS